Clinical studies of acute myeloid leukemia in the Japan Adult Leukemia Study Group
S Miyawaki - International journal of hematology, 2012 - Springer
Acute myeloid leukemia (AML) is the most common adult leukemia in Japan. The treatment
for AML consists of induction, consolidation, and maintenance therapies. To improve …
for AML consists of induction, consolidation, and maintenance therapies. To improve …
Efficacy of allogeneic hematopoietic stem cell transplantation in intermediate-risk acute myeloid leukemia adult patients in first complete remission: a meta-analysis of …
D Li, L Wang, H Zhu, L Dou, D Liu, L Fu, C Ma, X Ma… - PLoS …, 2015 - journals.plos.org
Hematopoietic stem cell transplantation (HSCT) and consolidation chemotherapy have been
used to treat intermediate-risk acute myeloid leukemia (AML) patients in first complete …
used to treat intermediate-risk acute myeloid leukemia (AML) patients in first complete …
Current Controversies: Which Patients With Acute Myeloid Leukaemia Should Receive A Bone Marrow Transplantation?–An Adult Treater's View.
AK Burnett - British journal of haematology, 2002 - search.ebscohost.com
Comments on the controversy on which patients with acute myeloid leukemia (AML) should
received a bone marrow transplantation. Overview of the clinical trials conducted in adults …
received a bone marrow transplantation. Overview of the clinical trials conducted in adults …
Prognostic factors influencing clinical outcome of allogeneic hematopoietic stem cell transplantation following imatinib-based therapy in BCR–ABL-positive ALL
We investigated prognostic factors for the clinical outcome of allogeneic hematopoietic stem
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …
cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute …
Role of allogeneic stem cell transplantation in current treatment of acute myeloid leukemia
JJ Cornelissen, B Löwenberg - ASH Education Program Book, 2005 - ashpublications.org
Allogeneic hematopoietic stem cell transplantation (alloSCT) has been established as an
effective consolidation therapy in acute myeloid leukemia (AML) in first or subsequent …
effective consolidation therapy in acute myeloid leukemia (AML) in first or subsequent …
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®)(FLAD) in primary refractory or relapsed adult …
A Camera, CR Rinaldi, S Palmieri, N Cantore… - Annals of …, 2009 - Springer
A large proportion of adult patients with acute myeloid leukemia (AML) relapse after
treatment, and some of them are resistant to primary induction chemotherapy. Sixty-one …
treatment, and some of them are resistant to primary induction chemotherapy. Sixty-one …
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective
M Yanada - International journal of hematology, 2015 - Springer
Allogeneic hematopoietic cell transplantation (HCT) is the most potent therapy for preventing
relapse of acute myeloid leukemia (AML). Although its efficacy is compromised by a high risk …
relapse of acute myeloid leukemia (AML). Although its efficacy is compromised by a high risk …
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive …
M Oosterveld, S Suciu, G Verhoef, B Labar, A Belhabri… - Leukemia, 2003 - nature.com
This report used the framework of a large European study to investigate the outcome of
patients with and without an HLA-identical sibling donor on an intention-to-treat basis. After …
patients with and without an HLA-identical sibling donor on an intention-to-treat basis. After …
[PDF][PDF] Strategies in the treatment of acute myeloid leukemia
B Lowenberg - Haematologica, 2004 - haematologica.org
The term acute myeloid leukemia (AML) collectively refers to a mixture of distinct diseases
that differ with regard to their pathogenetic evolution, genetic abnormalities, clinical features …
that differ with regard to their pathogenetic evolution, genetic abnormalities, clinical features …
Factors affecting long‐term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult …
HT Greinix, D Nachbaur, O Krieger… - British journal of …, 2002 - Wiley Online Library
Between 1982 and 2000, 172 patients with acute myelogenous leukaemia (AML) received
haematopoietic stem cell transplants (SCT) from related (n= 132) or unrelated (n= 40) …
haematopoietic stem cell transplants (SCT) from related (n= 132) or unrelated (n= 40) …